Ethosomes and lipid-coated chitosan nanocarriers for skin delivery of a chlorophyll derivative: A potential treatment of squamous cell carcinoma by photodynamic therapy.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
10 Sep 2019
Historique:
received: 21 03 2019
revised: 01 07 2019
accepted: 14 07 2019
pubmed: 20 7 2019
medline: 24 1 2020
entrez: 20 7 2019
Statut: ppublish

Résumé

Photodynamic therapy (PDT) is a localized treatment strategy used for skin cancers such as squamous cell carcinoma (SCC), the second most common form of skin cancer. PDT combines a photosensitizer, laser source and tissue oxygen. In this study, the selected photosensitizer, ferrous chlorophyllin (Fe-CHL) was loaded in ethosomes and lipid coated chitosan (PC/CHI) nanocarriers to enhance skin delivery of Fe-CHL for potential PDT of squamous carcinoma. The nanocarrier formulations were characterized and studied for their skin retention and penetration depth of Fe-CHL across mouse skin ex vivo using high performance liquid chromatography and confocal microscopy. Confocal microscope images of mouse skin showed deeper penetration of ethosomes down to the dermis when compared to PC/CHI that was confined to the epidermis, although they showed no significant difference in skin retention. Immunohistochemistry (IHC) staining with ki67 and TUNEL show maintained skin structure and no cytotoxic effects of the nanocarrier gel formulations before laser exposure to mouse skin. The nanocarriers were also studied for their PDT effect against human SCC monolayer and three-dimensional (3-D) spheroids. When compared to ethosomes, PC/CHI showed higher cytotoxicity in MTT assay and live confocal microscopy showed cell disintegration after laser exposure. For 3-D spheroids, PC/CHI also showed higher cytotoxicity using acid phosphatase assay and a decrease in spheroid size was observed using light microscopy. In conclusion, both types of nanocarriers can be used for their potential treatment of SCC using PDT depending on the tumour localization in the skin.

Identifiants

pubmed: 31323373
pii: S0378-5173(19)30572-1
doi: 10.1016/j.ijpharm.2019.118528
pii:
doi:

Substances chimiques

Chlorophyllides 0
Drug Carriers 0
Ferrous Compounds 0
Lipids 0
Photosensitizing Agents 0
Chitosan 9012-76-4
chlorophyllin EEM82VOY7C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118528

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Soad Nasr (S)

Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, D-89081 Ulm, Germany; Department of Chemistry, School of Sciences and Engineering, American University in Cairo (AUC), Egypt.

Mai Rady (M)

Pharmaceutical Technology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo (GUC). Main Entrance of Al-Tagamoa Al-Khames New Cairo City, Egypt.

Iman Gomaa (I)

Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Egypt. Electronic address: igomaa@msa.eun.eg.

Tatiana Syrovets (T)

Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, D-89081 Ulm, Germany.

Thomas Simmet (T)

Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, D-89081 Ulm, Germany.

Walid Fayad (W)

Drug Bioassay-Cell Culture Laboratory, Pharmacognosy Department, National Research Centre, Dokki, Giza 12622, Egypt.

Mahmoud Abdel-Kader (M)

National Institute of Laser Enhanced Sciences (NILES), Cairo University (CU), Giza, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH